6 chapters across the catalog
NPR Report on Ivermectin, Functional Medicine
An NPR report by the disinformation team profiles a woman who died of COVID-19 after refusing vaccines and seeking "unproven" treatments like Ivermectin. The report targets Dr. Pierre Kory and other "fringe" doctors who prescribe alternative medications. The discussion notes the growing popularity of "functional medicine" as patients lose trust in the Western medical establishment.
Joe Rogan recently claimed that 200 members of Congress were treated with Ivermectin for COVID-19, a detail reportedly shared by Dr. Pierre Kory. While the media has often dismissed the drug as "horse dewormer," the NIH added Ivermectin to its "Table 2E" of antiviral agents under evaluation for COVID-19 treatment in July 2021.
Dr. Pierre Kory, Ivermectin vs. Patented Drugs
Dr. Pierre Kory argues that Ivermectin is a highly effective, low-cost treatment for COVID-19 that is being ignored in favor of expensive, patented drugs. He claims that over 100,000 American lives could have been saved if the NIH had adopted Ivermectin protocols earlier.
Joe Rogan released an "emergency broadcast" featuring Dr. Pierre Kory and Brett Weinstein to discuss the benefits of ivermectin. The timing of the broadcast is noted as potentially softening the public for the eventual acceptance of the drug as a legitimate treatment.
Bret Weinstein and Pierre Kory, Ivermectin Censorship
Biologist Bret Weinstein's interview with Dr. Pierre Kory regarding Ivermectin is discussed in the context of YouTube censorship. While the episode is praised for its content, Weinstein is criticized for not embracing the "Value for Value" model or Podcasting 2.0 to protect his livelihood from platform strikes. The hosts note they have been covering Ivermectin and hydroxychloroquine for over a year.
Pierre Kory, Ivermectin Miraculous Impact Testimony
Dr. Pierre Kory testified before the Senate, claiming that ivermectin has a "miraculous impact" on COVID-19 transmission and mortality. Representing the Front Line COVID-19 Critical Care Alliance, Kory cited mountains of data from randomized controlled trials showing the drug's effectiveness as a prophylactic. He expressed frustration that the NIH has not updated its recommendations to include repurposed drugs.
